logo
PricingOpen Demat Account at ₹0 AMCBecome a PartnerCustomer ServiceDhan SupportDhan Blog
fuzz
Logo
MadeForTrade CommunityIndicator by Dhan
Home
InvestmentsIPOPharmeasy IPO

Pharmeasy IPO

Mainboard

Open Date

-

Close Date

-

Min Investment

-

Lot Size

-

Issue Size

-

Price Range

-

Subscribed

-
status

Upcoming IPO.

About the Company
PharmEasy (API Holdings Ltd), founded by Dharmil Sheth and Dhaval Shah, is one of India’s leading digital healthcare platforms. Positioned as a full-stack online healthcare “super app,” it offers a wide suite of services including e-pharmacy, teleconsultations, at-home diagnostics, and chronic care management. The platform enables the delivery of over 1 lakh medicines and health products across 19,000+ pin codes and 1,000+ cities, through its extensive retail partner network. PharmEasy simplifies healthcare access by offering doorstep delivery of prescription drugs, wellness items, and lab test bookings, all from a single interface. As of FY21, it had over 25 million registered users, with 2.4 million transacting customers and 8.8 million total orders. Its scale, tech-driven operations, and broad reach make it a category-defining player in India’s digital health ecosystem.
rocket

Founded In

2015

rocket

CEO

Siddharth Shah

Utilisation of Proceeds

PurposeAmount
PharmEasy aims to raise ₹6,250 crores through its IPO. Out of this, ₹1,929 crores will be used to repay or prepay existing borrowings, helping improve its balance sheet and reduce financial liabilities.-
Around ₹1,259 crores will be allocated to drive organic growth by investing in technology upgrades, expanding product offerings, and enhancing supply chain and infrastructure to support long-term business sustainability.-
₹1,500 crores will support PharmEasy’s inorganic growth through strategic acquisitions, mergers, and other business development initiatives aimed at expanding market reach and diversifying its service offerings.-
The remaining funds will be used for general corporate purposes, including operational expenses, administrative costs, and potential future requirements that support the overall functioning and flexibility of the business.-
border
  • Strong Investor Backing:: PharmEasy is supported by prominent investors including Manipal Group, Prosus Ventures, and Temasek. This strong backing not only provides financial stability but also enhances the company’s market credibility, enabling access to strategic guidance, long-term capital, and increased confidence among stakeholders and potential public market investors.
  • Large Integrated Healthcare Platform:: Operating under parent company API Holdings, PharmEasy offers a wide range of services including online medicine delivery, diagnostics, and teleconsultations. This positions it as India’s largest integrated digital healthcare platform, offering end-to-end solutions across the healthcare value chain and enhancing customer convenience.
  • Reduced Net Loss Through Lower Impairment Charges:: PharmEasy significantly reduced its net loss to ₹2,533 crore in FY24, down from ₹5,212 crore in FY23. This improvement was largely due to a sharp decline in goodwill impairment charges, which fell to ₹582 crore from ₹2,826 crore the previous year.
  • Omnichannel Service Offering:: PharmEasy has expanded beyond online pharmacy into teleconsultations, diagnostics, and distribution of medical devices and equipment. This diversified, omnichannel model helps reduce dependency on a single revenue stream and strengthens its position as a comprehensive digital healthcare provider.
  • Strategic M&A Strategy:: PharmEasy has executed key acquisitions including Medlife (2021), Thyrocare, and Aknamed, strategically integrating pharmacy, diagnostics, and healthcare supply chain services. These moves have expanded its operational scale, enhanced service depth, and strengthened its presence across multiple segments of the healthcare ecosystem.
  • Extensive Healthcare Network:: PharmEasy’s platform integrates a vast network of 87,000+ pharmacies, 3,200+ wholesalers, 4,600+ doctors, and nearly 1,000 hospitals, enabling end-to-end digital healthcare access across diagnostics, consultations, and medicine delivery.

Open IPOs for Subscription

No Open IPOs

Stay tuned, there will be more IPOs listing soon!


fuzz

Listed IPOs

No Listed IPOs

Stay tuned, there will be more IPOs listing soon!


Invest & Trade with a Trading
Platform That's #MadeForTrade

Open your Dhan Account in minutes!
border

Explore  |  Sitemap

*All securities mentioned on this website are exemplary and not recommendatory.

*Current prices on the website are delayed by 15 mins, login to check live prices.

We are bullish on India, we are bullish on India's prospects to be one of the largest economies in the world. We believe that the stock market provides a unique opportunity for all of India's traders and investors to participate in the growth story of the country.

Yet, most investing & trading platforms in India have remained more or less the same over the past decade. Times have changed and retail traders and investors have become smarter about managing their trades and money. Modern traders & investors require an online trading platform that helps them keep up with the technological advancements of our time.

That's why we're building Dhan - to help you trade, to help you invest, and to help you participate in India's growth stock via the stock market with awesome features and an incredible experience.

©2021-2026 Raise Securities Private Limited (formerly Moneylicious Securities Private Limited). All rights reserved. CIN: U74999MH2012PTC433549 Raise Securities is part of Raise Financial Services.

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357
Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320
Registered & Corporate Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai – 400104, Customer Care: 9987761000.


For any query / feedback / clarifications, email at help@dhan.co.

In case of grievances for any of the services rendered by Raise Securities Private Limited, please write to grievance@dhan.co (for NSE, BSE and MCX) or grievancedp@dhan.co (for Depository Participant). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms of Use and Privacy Policy. Compliance Officer: Mr. Manish Garg and Mobile: 8655740961 Email: complianceofficer@dhan.co To lodge your complaints using SEBI SCORES, click here.


Disclaimer: All communications with the client via chat, phone, or email are for support purposes only. Any commitments or statements made by the agent (human or virtual) shall not be binding on the company.


DHAN is a brand owned by Raise Securities Private Limited. All DHAN clients are registered under Raise Securities Private Limited. Clients are advised to refer to our company as Raise Securities Private Limited when communicating with regulatory authorities.


Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances. You may refer the website https://scores.sebi.gov.in/ for more information. You may also download the SEBI Scores app to log a complaint Android: https://play.google.com store apps sebiscores iOS: https://apps.apple.com app sebiscores.


Disclaimer: Investment in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit


Attention investors:

  1. Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
  2. Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
  3. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.

Note: As a policy we do not give stock tips or recommendations and have not authorized anyone to give this on behalf of us. If you know anyone claiming to be a part of Dhan / / Raise or our associate companies or partners and offering such services, please report us on help@dhan.co. Important Information for Investors: To prevent unauthorized transactions in your trading / demat account, do not share your account details, credentials or any personal details with anyone. Keep your mobile number updated with your Stock Broker, Depository Participant and ensure that the same is registered with Stock Exchanges, Depository and KRAs. You will receive alerts and information on your registered mobile number / email for debit and other important transactions in your demat account directly from CDSL / Exchange on the same day. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Stock Broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. This is issued in the interest of investors.


Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website. Issued in the interest of the investors.


Raise Securities Private Limited also known as Dhan is only an order collection platform that collects orders on behalf of clients and places them on BSE StarMF for execution. Client expressly agrees that Dhan is not liable or responsible and does not represent or warrant any damages regarding non- execution of orders or any incorrect execution of orders with regard to the funds chosen by the client or due to, but not being limited to, any link/system failure, delay in transfer of the funds on account of any unforeseen circumstances/issues in the banking system/payment aggregators or any other problems that may result in a delay in crediting the funds into the BSE Star MF's bank account. Raise Securities Private Limited (Dhan) does not engage in proprietary trading on its own account.


Mutual fund investments are subject to market risks, read all scheme related documents carefully before investing. Dhan is not a distributor or agent of any mutual fund. Mutual Funds are not exchange-traded products. Any related disputes will not have access to the Exchange-investor redressal forum or arbitration mechanism. For other disclaimers please refer https://dhan.co/advertisement-disclaimer/


Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: BSE | NSE | MCX


Kindly, read the Advisory Guidelines of BSE | NSE | MCX for investors as prescribed by the exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client's assets


Important Links: SEBI | BSE | NSE | MCX | CDSL | SCORES | ODR Portal | Investor Charter for Stock Brokers | Investor Charter for DP | Investor Charter for Research Analyst | UCC Advisory | e-Voting for Shareholders | NCL Client Collateral details |
MCXCCL Client Collateral details

Important Information: Terms of Usage | Disclaimers | Privacy Policy | Grievances | Grievances RA | Risk Management Policy | Risk Disclosure | Advertisement Disclaimer | Referral Terms & Conditions | Saarthi 2.0 Mobile App for Investors